Assay News and Research

RSS

Using dried blood spots to monitor SARS-CoV-2 antibodies at home

The Roche Elecsys® anti-SARS-CoV-2 S immunoassay was used to demonstrate its ability to measure SARS-CoV-2 antibodies from DBS samples.

28 Nov 2021

How often does SARS-CoV-2 infect alongside another viruses?

Researchers have been exploring data from COVID-19 patients tested at hospitals or clinics that also look for evidence of other diseases.

28 Nov 2021

Seroprevalence study reveals high exposure to SARS-CoV-2 in Bangui population

Researchers performed a cross-sectional study in the city of Bangui, the capital of the Central African Republic from July 12, 2021, to August 20, 2021.

28 Nov 2021

Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine

A study developed a protein-based subunit vaccine, PHH-1V, that consisted of a recombinant RBD fusion heterodimer of the alpha) and beta variants of SARS-CoV-2.

26 Nov 2021

Antiviral activity of a photoactivable natural product on coronaviruses

A new study showed that pheophorbide a has antiviral activity against many CoVs.

26 Nov 2021

Cerba Research Expands U.S. Immuno-Oncology Center of Excellence to Strengthen Its Precision Medicine Offerings

Cerba Research recently expanded. Our U.S. Immuno-Oncology Center of Excellence allows us to provide even more comprehensive, integrated central lab services, specialty lab and biomarker solutions, and diagnostic services worldwide.

From Cerba Research 25 Nov 2021

Serum SARS-CoV-2 antigen: A better predictor of COVID-19 severity

In this perspective, a new study published on the medRxiv* preprint server analyzed the clinical efficacy of two serum antigen tests to identify SARS CoV-2 infection and evaluate the kinetics of serum nucleocapsid (N) antigen in severe and non-severe patients for disease severity prediction.

24 Nov 2021

Novel method enables deeper analysis of endocrine disrupting chemicals' impact on gene expression

When something disrupts hormone binding to the receptor, such as environmental compounds or pollutants, called endocrine disrupting chemicals (EDCs), the results can be harmful and, in some cases, lead to certain forms of cancer.

24 Nov 2021

Antibody persistence in infants after maternal COVID-19 vaccination

New research finds COVID-19 vaccination during pregnancy results in significantly greater antibody persistence in the infants compared to natural infection of the mothers during pregnancy.

24 Nov 2021

Discovery of a broad-spectrum antiviral activity in self-assembling immunostimulatory duplex RNAs

A new study, published on the bioRxiv* preprint server, has discovered a class of new immunostimulatory RNAs while studying influenza infection-associated host genes in human lung epithelial cells using small interfering RNAs (siRNAs). Scientists revealed that these short duplex RNAs could induce type I and type III interferons (IFN-I/III) in a wide variety of cells.

23 Nov 2021

Mouthwash containing an antiviral phthalocyanine derivative shortens hospitalizations due to COVID-19

In a study published in the journal Scientific Reports, a research group from Brazil showed how antiviral anionic phthalocyanine derivative used in a mouthwash protocol may not only reduce the symptoms of coronavirus disease (COVID-19), but also hamper the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

23 Nov 2021

Oral Hsp90 inhibitor SNX-5422 interferes with replication machinery of SARS-CoV-2

A new study evaluates the efficacy of SNX-5422 as a post-exposure prophylactic treatment.

23 Nov 2021

Strong antibody responses against harmless coronaviruses may protect against SARS-CoV-2

Infections with the novel coronavirus and vaccination lead to strong antibody responses against SARS-CoV-2. Immune responses to other human coronaviruses, which mostly only cause harmless colds, also provide some protection against SARS-CoV-2.

23 Nov 2021

Antigenic cocktail produced in Nicotiana benthamian plant as a potential COVID-19 vaccine candidate

Scientists utilize N. benthamiana for producing the N-protein and an antigenic cocktail containing the N-protein and SARS-CoV-2 S RBD.

23 Nov 2021

Tobacco mosaic virus nanoparticle-based novel COVID-19 vaccine candidate

Scientists generate a VLP type NP platform made of recombinant viral antigens conjugated with TMV virions.

23 Nov 2021

How the new In-Vitro Diagnostics Regulations are affecting the life sciences landscape

In this interview, News-Medical talks to Laura Nea, Vice President of Quality and Regulatory Management at Tecan, about the upcoming changes to the regulations surrounding in-vitro diagnostics and how they might affect the life sciences landscape.

From Tecan 23 Nov 2021

Researchers make progress towards a new diagnostic test for schistosomiasis

Researchers have made important progress towards a new diagnostic test for schistosomiasis, which could help the World Health Organization achieve its goal of interrupting transmission of the disease, and eventually eliminating it.

22 Nov 2021

Paper-based innovations for COVID-19 diagnosis

A review discusses paper-based devices and platforms targeting SARS-CoV-2 for low-cost PoC diagnosis and serological antibody testing.

22 Nov 2021

Detection of SARS-CoV-2 spike antibody using electrochemical biosensing based on hydrogen bonding

Turkish researchers discuss their rapid electrochemical biosensing platform to detect the SARS-CoV-2 spike antibody.

22 Nov 2021

SARS-CoV-2 infection risk in Norwegian fitness centers

Researchers from the University of Oslo oversaw a trial in Norway in which several fitness centers were allowed to open.

22 Nov 2021

Assay News and Research

Using dried blood spots to monitor SARS-CoV-2 antibodies at home

How often does SARS-CoV-2 infect alongside another viruses?

Seroprevalence study reveals high exposure to SARS-CoV-2 in Bangui population

Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine

Antiviral activity of a photoactivable natural product on coronaviruses

Cerba Research Expands U.S. Immuno-Oncology Center of Excellence to Strengthen Its Precision Medicine Offerings

Serum SARS-CoV-2 antigen: A better predictor of COVID-19 severity

Novel method enables deeper analysis of endocrine disrupting chemicals' impact on gene expression

Antibody persistence in infants after maternal COVID-19 vaccination

Discovery of a broad-spectrum antiviral activity in self-assembling immunostimulatory duplex RNAs

Mouthwash containing an antiviral phthalocyanine derivative shortens hospitalizations due to COVID-19

Oral Hsp90 inhibitor SNX-5422 interferes with replication machinery of SARS-CoV-2

Strong antibody responses against harmless coronaviruses may protect against SARS-CoV-2

Antigenic cocktail produced in Nicotiana benthamian plant as a potential COVID-19 vaccine candidate

Tobacco mosaic virus nanoparticle-based novel COVID-19 vaccine candidate

How the new In-Vitro Diagnostics Regulations are affecting the life sciences landscape

Researchers make progress towards a new diagnostic test for schistosomiasis

Paper-based innovations for COVID-19 diagnosis

Detection of SARS-CoV-2 spike antibody using electrochemical biosensing based on hydrogen bonding

SARS-CoV-2 infection risk in Norwegian fitness centers

eBook: Using iPSCs models for human disease research and drug discovery eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News